| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 15, 2025 | Aug 19, 2025 | Replimune Group, Inc. | CFO | Sell | 46.3 | -9,154 | -6.38% | ✗ | $49.2K |
| May 20, 2025 | May 22, 2025 | Replimune Group, Inc. | CFO | Sell | 46.3 | -2,535 | -1.74% | ✗ | $20.4K |
| Aug 16, 2024 | Aug 19, 2024 | Replimune Group, Inc. | CFO | Sell | 42.5 | -8,938 | -8.13% | ✗ | $91K |
| Mar 27, 2023 | Mar 29, 2023 | PTC THERAPEUTICS, INC. | CFO | Sell | 17.5 | -7,363 | -15.91% | ✓ | $331.3K |
| Jan 31, 2023 | Feb 2, 2023 | PTC THERAPEUTICS, INC. | CFO | Sell | 46.3 | -575 | -1.23% | ✗ | $26.2K |
| Jan 24, 2023 | Jan 26, 2023 | PTC THERAPEUTICS, INC. | CFO | Sell | 51.3 | -223 | -0.47% | ✗ | $10.6K |
| Jan 10, 2023 | Jan 12, 2023 | PTC THERAPEUTICS, INC. | CFO | Sell | 46.3 | -915 | -1.91% | ✗ | $39.9K |
| Jan 9, 2023 | Jan 11, 2023 | PTC THERAPEUTICS, INC. | CFO | Sell | 46.3 | -758 | -1.55% | ✗ | $31.6K |
| Mar 31, 2022 | Apr 1, 2022 | PTC THERAPEUTICS, INC. | CFO | Sell | 12.5 | -7,910 | -21.28% | ✓ | $298.8K |
| Feb 1, 2022 | Feb 3, 2022 | PTC THERAPEUTICS, INC. | CFO | Sell | 46.3 | -553 | -1.47% | ✗ | $22.1K |
| Jan 25, 2022 | Jan 27, 2022 | PTC THERAPEUTICS, INC. | CFO | Sell | 50.0 | -211 | -0.56% | ✗ | $8.3K |
| Jan 7, 2022 | Jan 11, 2022 | PTC THERAPEUTICS, INC. | CFO | Sell | 91.3 | +14,800 | 63.98% | ✗ | $30.8K |
| Jan 4, 2022 | Jan 6, 2022 | PTC THERAPEUTICS, INC. | CFO | Sell | 50.0 | -173 | -0.74% | ✗ | $7.1K |
| Feb 1, 2021 | Feb 2, 2021 | PTC THERAPEUTICS, INC. | CFO | Sell | 46.3 | -541 | -2.27% | ✗ | $30.8K |
| Jan 25, 2021 | Jan 27, 2021 | PTC THERAPEUTICS, INC. | CFO | Sell | 46.3 | -275 | -1.14% | ✗ | $17.1K |
| Jan 8, 2021 | Jan 12, 2021 | PTC THERAPEUTICS, INC. | CFO | Sell | 10.0 | -26,033 | -21.25% | ✓ | $1.8M |
| Jan 5, 2021 | Jan 7, 2021 | PTC THERAPEUTICS, INC. | CFO | Sell | 46.3 | -288 | -2.12% | ✗ | $18K |
| Jun 29, 2020 | Jul 1, 2020 | PTC THERAPEUTICS, INC. | CFO | Sell | 20.0 | -2,581 | -15.94% | ✓ | $135.5K |
| Jan 23, 2020 | Jan 27, 2020 | PTC THERAPEUTICS, INC. | CFO | Sell | 46.3 | -330 | -4.57% | ✗ | $17.6K |
| Jan 6, 2020 | Jan 8, 2020 | PTC THERAPEUTICS, INC. | CFO | Sell | 46.3 | -384 | -5.05% | ✗ | $18.6K |